Compared with other groups, RGD@LP-Y+RT-treated tumor cells exhibited a marked reduction in COX IV activity (Figure 6E), which may lead to the reduction of oxygen consumption in solid tumors. The gene discussed is COX4I1; the disease is neoplasm.